Thu, Aug 22 11:43am


Altimmune, Inc. - Common Stock [ALT]
$2.11 0.01 (0.48%)

ALT Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 30 Million
ALT Description

Altimmune Inc is a United States-based clinical stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of diseases. The firm's product candidates include NasoVAX, HepTcell, SparVax-L, NasoShield, and Oncosyn. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.


Visit Website

ALT Earnings

EPS -0.26 P/E Ratio 0.00
Previous Earnings Wed, May 15, 2019
Latest Earnings Wed, Aug 14, 2019 (8 days ago) +0.00%

ALT Dividend

Yield --
Ex-Date --
Pay Date --
History 9 Payments (Biannual)

ALT Charts

$1.70
1 Year
$36.25
Dec 24, 2018
Sep 20, 2018



Symbol Price Day % YTD %
ALT $2.11 -0.48% -19.23%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy